AbCellera Biologics Inc. Files 8-K
Ticker: ABCL · Form: 8-K · Filed: Feb 18, 2025 · CIK: 1703057
Sentiment: neutral
Topics: administrative, address-change
Related Tickers: ABCL
TL;DR
AbCellera updated its address on an 8-K filing. Nothing else major.
AI Summary
AbCellera Biologics Inc. filed an 8-K on February 18, 2025, to report other events. The filing provides updated address information for the company, located at 150 W 4th Avenue, Vancouver, BC V5Y 1G6. No other specific business events or financial transactions are detailed in this particular filing.
Why It Matters
This filing primarily serves as an administrative update regarding AbCellera's corporate address, indicating a change or confirmation of their principal executive office location.
Risk Assessment
Risk Level: low — The filing is administrative in nature, reporting an address change, and does not contain information that would immediately impact the company's stock price or operations.
Key Players & Entities
- AbCellera Biologics Inc. (company) — Registrant
- February 18, 2025 (date) — Date of Report
- 150 W 4th Avenue, Vancouver, BC V5Y 1G6 (address) — Registrant's principal executive office
FAQ
What is the primary purpose of this 8-K filing for AbCellera Biologics Inc.?
The primary purpose of this 8-K filing is to report 'Other Events', specifically updating the company's principal executive office address.
When was this 8-K filing submitted by AbCellera Biologics Inc.?
The filing was made on February 18, 2025.
What is the new or confirmed principal executive office address for AbCellera Biologics Inc.?
The principal executive office address is listed as 150 W 4th Avenue, Vancouver, BC V5Y 1G6.
Does this filing indicate any significant business developments or financial transactions for AbCellera Biologics Inc.?
No, this filing is administrative and primarily concerns an address update, not significant business developments or financial transactions.
What is the Commission File Number for AbCellera Biologics Inc. as listed in this filing?
The Commission File Number for AbCellera Biologics Inc. is 001-39781.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 18, 2025 regarding AbCellera Biologics Inc. (ABCL).